Modulators of voltage-dependent calcium channels for the treatment of nervous system diseases

Eiki Takahashi1, Kimie Niimi

  • 1Research Resources Center, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako, Saitama, Japan. etakahashi@brain.riken.jp

Insights

Voltage-dependent calcium channels (VDCCs) are crucial for nervous system function. Modulating VDCCs offers a promising therapeutic strategy for various central nervous system diseases by targeting specific channel types.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Voltage-dependent calcium channels (VDCCs) regulate critical neuronal processes like action potential generation and neurotransmitter release.
  • Dysregulation of calcium signaling through VDCCs is implicated in central nervous system (CNS) disorders such as pain, epilepsy, anxiety, and dementia.

Purpose of the Study:

  • To provide a comprehensive overview of VDCCs in the context of CNS diseases.
  • To review traditional and novel therapeutic strategies targeting VDCCs.
  • To explore the medicinal chemistry of VDCC blockers.

Main Methods:

  • Literature review of scientific and patent databases.
  • Analysis of traditional and emerging therapeutic fields related to VDCCs.
  • Examination of the medicinal chemistry of VDCC modulators.

Main Results:

  • VDCCs are key players in both normal neuronal function and the pathophysiology of CNS diseases.
  • Targeting specific VDCC isoforms offers a strategy to minimize adverse effects.
  • A diverse range of traditional and novel VDCC blockers are being developed.

Conclusions:

  • Modulation of VDCCs presents a viable therapeutic avenue for a spectrum of CNS disorders.
  • Selective targeting of disease-relevant VDCC subtypes is essential for effective and safe treatment.
  • Continued research into VDCC medicinal chemistry holds promise for future drug development.

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
The Role of Ion Channels in Neuronal Computation01:19

The Role of Ion Channels in Neuronal Computation

A postsynaptic neuron usually receives numerous impulses from several other presynaptic neurons. The axon hillock of the postsynaptic neuron integrates all these signals and determines the likelihood of firing an action potential.
Sometimes a single EPSP is strong enough to induce an action potential in the postsynaptic neuron. However, multiple presynaptic inputs must often create EPSPs around the same time for the postsynaptic neuron to be sufficiently depolarized to fire an action potential.